A detailed history of Toth Financial Advisory Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Toth Financial Advisory Corp holds 52 shares of GILD stock, worth $4,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52
Previous 52 -0.0%
Holding current value
$4,580
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$71.58 - $87.29 $7,158 - $8,729
-100 Reduced 65.79%
52 $3,000
Q4 2023

Jan 26, 2024

BUY
$73.27 - $83.09 $7,327 - $8,309
100 Added 192.31%
152 $12,000
Q3 2023

Oct 12, 2023

SELL
$73.94 - $80.67 $3,697 - $4,033
-50 Reduced 49.02%
52 $3,000
Q2 2023

Jul 24, 2023

SELL
$76.01 - $86.7 $76 - $86
-1 Reduced 0.97%
102 $7,000
Q1 2023

Apr 24, 2023

BUY
$77.31 - $88.08 $3,942 - $4,492
51 Added 98.08%
103 $8,000
Q4 2022

Jan 24, 2023

BUY
$62.32 - $89.47 $1,059 - $1,520
17 Added 48.57%
52 $0
Q3 2022

Oct 14, 2022

BUY
$59.54 - $68.01 $2,083 - $2,380
35 New
35 $2,000
Q4 2021

Jan 31, 2022

SELL
$64.88 - $73.64 $7,785 - $8,836
-120 Closed
0 $0
Q4 2020

Jan 25, 2021

SELL
$56.65 - $64.55 $11,330 - $12,910
-200 Reduced 62.5%
120 $7,000
Q3 2020

Oct 16, 2020

SELL
$62.1 - $78.08 $12,109 - $15,225
-195 Reduced 37.86%
320 $20,000
Q2 2020

Jul 14, 2020

BUY
$72.34 - $84.0 $28,574 - $33,180
395 Added 329.17%
515 $39,000
Q1 2020

Apr 20, 2020

BUY
$62.63 - $80.22 $7,515 - $9,626
120 New
120 $8,000
Q2 2018

Jul 23, 2018

SELL
$64.88 - $75.68 $8,888 - $10,368
-137 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$71.15 - $83.52 $9,747 - $11,442
137
137 $10,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Toth Financial Advisory Corp Portfolio

Follow Toth Financial Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.